Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio By means of Commercialization Settlement With Abbisko for Section III Asset, Pimicotinib
DARMSTADT, Germany–(BUSINESS WIRE)– Merck KGaA, Darmstadt, Germany, a number one science and expertise firm, at the moment introduced a license settlement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is at...